Search
for
Sort by
Research 271–300 of 1000+
- Sebum Production
- Pharmacology of anabolic steroids
- Deletion of Deoxyribonucleic Acid Binding Domain of the Vitamin D Receptor Abrogates Genomic and Nongenomic Functions of Vitamin D
- Polycystic Ovary Syndrome
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Generic Development of Topical Dermatologic Products: Formulation Development, Process Development, and Testing of Topical Dermatologic Products
- An Update of Congenital Adrenal Hyperplasia
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Dermatologic manifestations of endocrine disorders
- Management of Hair Loss
- Polycystic Ovary Syndrome: Diagnosis and Treatment
- DRUG‐ASSOCIATED ALOPECIA
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- Comparitive Effectiveness and Finasteride <i>Vs Serenoa Repens</i> in Male Androgenetic Alopecia: A Two-Year Study
- Idiopathic Hirsutism*
- Toxicologic studies with the hypotensive agent minoxidil
- Update on the dermatologic use of systemic glucocorticosteroids
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date
- Gender-Affirming Hormone Therapy for Transgender Females
- Women's midlife health Reframing menopause
- Thymosin β4 Promotes Dermal Healing
- New approaches to the treatment of osteoporosis
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates